Nisha Singh

Employment

• University of Oxford Senior Programme Manager
  2020 - Present
• University of Oxford Senior Postdoctoral Researcher
  2019 - 2021
• King's College London
  ? - 2019

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (57)

• A novel blood-free analytical framework for the quantification of neuroinflammatory load from TSPO PET Imaging
  Archives of Public Health 2025 DOI: 10.21203/rs.3.rs-5924801/v1
  +Save
• Altered oxidative neurometabolic response to methylene blue in bipolar disorder revealed by quantitative neuroimaging
  Journal of Affective Disorders 2024 DOI: 10.1016/j.jad.2024.07.029
  +Save
• The effects of acute Methylene Blue administration on cerebral blood flow and metabolism in humans and rats
  Journal of Cerebral Blood Flow & Metabolism 2023 DOI: 10.1177/0271678X231157958
  +Save
• Reactogenicity, immunogenicity and breakthrough infections following heterologous or fractional second dose COVID-19 vaccination in adolescents (Com-COV3): A randomised controlled trial
  Journal of Infection 2023 DOI: 10.1016/j.jinf.2023.06.007
  +Save
• Investigating brain alterations in the Dp1Tyb mouse model of Down syndrome
  Neurobiology of Disease 2023 DOI: 10.1016/j.nbd.2023.106336
  +Save
• GABAA and NMDA receptor density alterations and their behavioral correlates in the gestational methylazoxymethanol acetate model for schizophrenia
  Neuropsychopharmacology 2022 DOI: 10.1038/s41386-021-01213-0
  +Save
• Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial
  The Lancet 2022 DOI: 10.1016/S0140-6736(22)00770-X
  +Save
• Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
  The Lancet 2022 DOI: 10.1016/S0140-6736(21)02718-5
  +Save
• From bench to bedside: The mGluR5 system in people with and without Autism Spectrum Disorder and animal model systems
  Translational Psychiatry 2022 DOI: 10.1038/s41398-022-02143-1
  +Save
• An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
  eBioMedicine 2022 DOI: 10.1016/j.ebiom.2022.104128
  +Save